Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 3Leukemia 2Triple Negative Breast Neoplasms 1Recurrence 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Lymphoma 1Lung Neoplasms 1Estrogen Receptor Positive Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 5Dexamethasone 5Cytarabine 3Cyclophosphamide 3Vincristine 2Decitabine 2trametinib 1ruxolitinib 1pegaspargase 1nilotinib 1navitoclax 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1blinatumomab 1Vorinostat 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Dasatinib 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × capivasertib × Clear all
NCT07175415 2025-09-16

HEM-iSMART E

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡